APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cefdinir Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cefdinir Capsules Industry Research Report 2026

27 December 2025128 pages

Choose your research edition.

Industry ResearchCefdinir Capsules Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cefdinir Capsules Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Cefdinir Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cefdinir Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cefdinir Capsules Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Cefdinir Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Cefdinir Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Cefdinir Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Cefdinir Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Cefdinir Capsules include Chengdu Beite Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Hainan Rizhongtian Pharmaceutical Co., Ltd., Jiangsu Hausen Pharmaceutical Group Co., Ltd., Shenzhen Lijian Pharmaceutical Co., Ltd., Shijiazhuang Siyao Co., Ltd., Sichuan Saizhuo Pharmaceutical Co., Ltd., Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. and Zhejiang Jutai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Cefdinir Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cefdinir Capsules Market by Company

Chengdu Beite Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.

Hainan Rizhongtian Pharmaceutical Co., Ltd.

Jiangsu Hausen Pharmaceutical Group Co., Ltd.

Shenzhen Lijian Pharmaceutical Co., Ltd.

Shijiazhuang Siyao Co., Ltd.

Sichuan Saizhuo Pharmaceutical Co., Ltd.

Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd.

Zhejiang Jutai Pharmaceutical Co., Ltd.

Zhejiang Shapuaisi Pharmaceutical Co., Ltd.

Cefdinir Capsules Segment by Type

100mg

Other

Cefdinir Capsules Segment by Application

Hospital

Clinic

Other

Cefdinir Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefdinir Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cefdinir Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefdinir Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Cefdinir Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Cefdinir Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Cefdinir Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cefdinir Capsules Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Cefdinir Capsules Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Cefdinir Capsules Sales Market Share by Manufacturers (2021-2026) Table 8. Global Cefdinir Capsules Revenue of Manufacturers (2021-2026) Table 9. Global Cefdinir Capsules Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Cefdinir Capsules Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Cefdinir Capsules Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Cefdinir Capsules, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Cefdinir Capsules, Product Type & Application Table 14. Global Cefdinir Capsules Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Cefdinir Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chengdu Beite Pharmaceutical Co., Ltd. Company Information Table 19. Chengdu Beite Pharmaceutical Co., Ltd. Business Overview Table 20. Chengdu Beite Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chengdu Beite Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 22. Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments Table 23. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information Table 24. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview Table 25. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 27. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments Table 28. Hainan Rizhongtian Pharmaceutical Co., Ltd. Company Information Table 29. Hainan Rizhongtian Pharmaceutical Co., Ltd. Business Overview Table 30. Hainan Rizhongtian Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Hainan Rizhongtian Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 32. Hainan Rizhongtian Pharmaceutical Co., Ltd. Recent Developments Table 33. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information Table 34. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview Table 35. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Cefdinir Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Cefdinir Capsules Product Portfolio Table 37. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments Table 38. Shenzhen Lijian Pharmaceutical Co., Ltd. Company Information Table 39. Shenzhen Lijian Pharmaceutical Co., Ltd. Business Overview Table 40. Shenzhen Lijian Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Shenzhen Lijian Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 42. Shenzhen Lijian Pharmaceutical Co., Ltd. Recent Developments Table 43. Shijiazhuang Siyao Co., Ltd. Company Information Table 44. Shijiazhuang Siyao Co., Ltd. Business Overview Table 45. Shijiazhuang Siyao Co., Ltd. Cefdinir Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Shijiazhuang Siyao Co., Ltd. Cefdinir Capsules Product Portfolio Table 47. Shijiazhuang Siyao Co., Ltd. Recent Developments Table 48. Sichuan Saizhuo Pharmaceutical Co., Ltd. Company Information Table 49. Sichuan Saizhuo Pharmaceutical Co., Ltd. Business Overview Table 50. Sichuan Saizhuo Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Sichuan Saizhuo Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 52. Sichuan Saizhuo Pharmaceutical Co., Ltd. Recent Developments Table 53. Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Company Information Table 54. Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Business Overview Table 55. Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 57. Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Recent Developments Table 58. Zhejiang Jutai Pharmaceutical Co., Ltd. Company Information Table 59. Zhejiang Jutai Pharmaceutical Co., Ltd. Business Overview Table 60. Zhejiang Jutai Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Zhejiang Jutai Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 62. Zhejiang Jutai Pharmaceutical Co., Ltd. Recent Developments Table 63. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Company Information Table 64. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Business Overview Table 65. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 67. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Recent Developments Table 68. Global Cefdinir Capsules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Cefdinir Capsules Sales by Region (2021-2026) & (K Units) Table 70. Global Cefdinir Capsules Sales Market Share by Region (2021-2026) Table 71. Global Cefdinir Capsules Sales by Region (2027-2032) & (K Units) Table 72. Global Cefdinir Capsules Sales Market Share by Region (2027-2032) Table 73. Global Cefdinir Capsules Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Cefdinir Capsules Revenue Market Share by Region (2021-2026) Table 75. Global Cefdinir Capsules Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Cefdinir Capsules Revenue Market Share by Region (2027-2032) Table 77. North America Cefdinir Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Cefdinir Capsules Sales by Country (2021-2026) & (K Units) Table 79. North America Cefdinir Capsules Sales by Country (2027-2032) & (K Units) Table 80. North America Cefdinir Capsules Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Cefdinir Capsules Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Cefdinir Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Cefdinir Capsules Sales by Country (2021-2026) & (K Units) Table 84. Europe Cefdinir Capsules Sales by Country (2027-2032) & (K Units) Table 85. Europe Cefdinir Capsules Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Cefdinir Capsules Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Cefdinir Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Cefdinir Capsules Sales by Country (2021-2026) & (K Units) Table 89. Asia Pacific Cefdinir Capsules Sales by Country (2027-2032) & (K Units) Table 90. Asia Pacific Cefdinir Capsules Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Cefdinir Capsules Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Cefdinir Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Cefdinir Capsules Sales by Country (2021-2026) & (K Units) Table 94. South America Cefdinir Capsules Sales by Country (2027-2032) & (K Units) Table 95. South America Cefdinir Capsules Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Cefdinir Capsules Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Cefdinir Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Cefdinir Capsules Sales by Country (2021-2026) & (K Units) Table 99. Middle East and Africa Cefdinir Capsules Sales by Country (2027-2032) & (K Units) Table 100. Middle East and Africa Cefdinir Capsules Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Cefdinir Capsules Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Cefdinir Capsules Sales by Type (2021-2026) & (K Units) Table 103. Global Cefdinir Capsules Sales by Type (2027-2032) & (K Units) Table 104. Global Cefdinir Capsules Sales Market Share by Type (2021-2026) Table 105. Global Cefdinir Capsules Sales Market Share by Type (2027-2032) Table 106. Global Cefdinir Capsules Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Cefdinir Capsules Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Cefdinir Capsules Revenue Market Share by Type (2021-2026) Table 109. Global Cefdinir Capsules Revenue Market Share by Type (2027-2032) Table 110. Global Cefdinir Capsules Price by Type (2021-2026) & (US$/Unit) Table 111. Global Cefdinir Capsules Price by Type (2027-2032) & (US$/Unit) Table 112. Global Cefdinir Capsules Sales by Application (2021-2026) & (K Units) Table 113. Global Cefdinir Capsules Sales by Application (2027-2032) & (K Units) Table 114. Global Cefdinir Capsules Sales Market Share by Application (2021-2026) Table 115. Global Cefdinir Capsules Sales Market Share by Application (2027-2032) Table 116. Global Cefdinir Capsules Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Cefdinir Capsules Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Cefdinir Capsules Revenue Market Share by Application (2021-2026) Table 119. Global Cefdinir Capsules Revenue Market Share by Application (2027-2032) Table 120. Global Cefdinir Capsules Price by Application (2021-2026) & (US$/Unit) Table 121. Global Cefdinir Capsules Price by Application (2027-2032) & (US$/Unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Cefdinir Capsules Distributors List Table 125. Cefdinir Capsules Customers List Table 126. Cefdinir Capsules Industry Trends Table 127. Cefdinir Capsules Industry Drivers Table 128. Cefdinir Capsules Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cefdinir Capsules Product Image Figure 5. Global Cefdinir Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Cefdinir Capsules Market Size (2021-2032) & (US$ Million) Figure 7. Global Cefdinir Capsules Sales (2021-2032) & (K Units) Figure 8. Global Cefdinir Capsules Average Price (US$/Unit) & (2021-2032) Figure 9. 100mg Product Image Figure 10. Other Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Cefdinir Capsules Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Cefdinir Capsules, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Cefdinir Capsules Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Cefdinir Capsules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Cefdinir Capsules Sales by Region in 2025 Figure 20. Global Cefdinir Capsules Revenue by Region in 2025 Figure 21. North America Cefdinir Capsules Market Size by Country in 2025 Figure 22. North America Cefdinir Capsules Sales Market Share by Country (2021-2032) Figure 23. North America Cefdinir Capsules Revenue Market Share by Country (2021-2032) Figure 24. United States Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Cefdinir Capsules Market Size by Country in 2025 Figure 28. Europe Cefdinir Capsules Sales Market Share by Country (2021-2032) Figure 29. Europe Cefdinir Capsules Revenue Market Share by Country (2021-2032) Figure 30. Germany Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Cefdinir Capsules Market Size by Country in 2025 Figure 41. Asia Pacific Cefdinir Capsules Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Cefdinir Capsules Revenue Market Share by Country (2021-2032) Figure 43. China Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Cefdinir Capsules Market Size by Country in 2025 Figure 52. South America Cefdinir Capsules Sales Market Share by Country (2021-2032) Figure 53. South America Cefdinir Capsules Revenue Market Share by Country (2021-2032) Figure 54. Brazil Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Cefdinir Capsules Market Size by Country in 2025 Figure 59. Middle East and Africa Cefdinir Capsules Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Cefdinir Capsules Revenue Market Share by Country (2021-2032) Figure 61. Egypt Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Cefdinir Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Cefdinir Capsules Sales Market Share by Type (2021-2032) Figure 67. Global Cefdinir Capsules Revenue Market Share by Type (2021-2032) Figure 68. Global Cefdinir Capsules Price (US$/Unit) by Type (2021-2032) Figure 69. Global Cefdinir Capsules Sales Market Share by Application (2021-2032) Figure 70. Global Cefdinir Capsules Revenue Market Share by Application (2021-2032) Figure 71. Global Cefdinir Capsules Price (US$/Unit) by Application (2021-2032) Figure 72. Cefdinir Capsules Value Chain Figure 73. Cefdinir Capsules Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Cefdinir Capsules Industry Opportunities and Challenges

Scope & coverage.

Types
  • 100mg
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chengdu Beite Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  • Hainan Rizhongtian Pharmaceutical Co., Ltd.
  • Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  • Shenzhen Lijian Pharmaceutical Co., Ltd.
  • Shijiazhuang Siyao Co., Ltd.
  • Sichuan Saizhuo Pharmaceutical Co., Ltd.
  • Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd.
  • Zhejiang Jutai Pharmaceutical Co., Ltd.
  • Zhejiang Shapuaisi Pharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Cefdinir Capsules Market Size (2021-2032)
  4. 2.2.2 Global Cefdinir Capsules Sales (2021-2032)
  5. 2.2.3 Global Cefdinir Capsules Market Average Price (2021-2032)
  6. 2.3 Cefdinir Capsules by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 100mg
  9. 2.3.3 Other
  10. 2.4 Cefdinir Capsules by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cefdinir Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Cefdinir Capsules Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Cefdinir Capsules Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Cefdinir Capsules Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Cefdinir Capsules Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Cefdinir Capsules, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Cefdinir Capsules, Product Type & Application
  8. 3.8 Global Manufacturers of Cefdinir Capsules, Established Date
  9. 3.9 Global Cefdinir Capsules Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chengdu Beite Pharmaceutical Co., Ltd.
  2. 4.1.1 Chengdu Beite Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Chengdu Beite Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Chengdu Beite Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chengdu Beite Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  6. 4.1.5 Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  8. 4.2.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  12. 4.2.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Hainan Rizhongtian Pharmaceutical Co., Ltd.
  14. 4.3.1 Hainan Rizhongtian Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Hainan Rizhongtian Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Hainan Rizhongtian Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Hainan Rizhongtian Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  18. 4.3.5 Hainan Rizhongtian Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  20. 4.4.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
  21. 4.4.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
  22. 4.4.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Cefdinir Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Cefdinir Capsules Product Portfolio
  24. 4.4.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
  25. 4.5 Shenzhen Lijian Pharmaceutical Co., Ltd.
  26. 4.5.1 Shenzhen Lijian Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Shenzhen Lijian Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Shenzhen Lijian Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Shenzhen Lijian Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  30. 4.5.5 Shenzhen Lijian Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Shijiazhuang Siyao Co., Ltd.
  32. 4.6.1 Shijiazhuang Siyao Co., Ltd. Company Information
  33. 4.6.2 Shijiazhuang Siyao Co., Ltd. Business Overview
  34. 4.6.3 Shijiazhuang Siyao Co., Ltd. Cefdinir Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Shijiazhuang Siyao Co., Ltd. Cefdinir Capsules Product Portfolio
  36. 4.6.5 Shijiazhuang Siyao Co., Ltd. Recent Developments
  37. 4.7 Sichuan Saizhuo Pharmaceutical Co., Ltd.
  38. 4.7.1 Sichuan Saizhuo Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Sichuan Saizhuo Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Sichuan Saizhuo Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Sichuan Saizhuo Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  42. 4.7.5 Sichuan Saizhuo Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd.
  44. 4.8.1 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  48. 4.8.5 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Zhejiang Jutai Pharmaceutical Co., Ltd.
  50. 4.9.1 Zhejiang Jutai Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Zhejiang Jutai Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Zhejiang Jutai Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Zhejiang Jutai Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  54. 4.9.5 Zhejiang Jutai Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
  56. 4.10.1 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  60. 4.10.5 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Recent Developments
5 Global Cefdinir Capsules Market Scenario by Region
  1. 5.1 Global Cefdinir Capsules Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cefdinir Capsules Sales by Region: 2021-2032
  3. 5.2.1 Global Cefdinir Capsules Sales by Region: 2021-2026
  4. 5.2.2 Global Cefdinir Capsules Sales by Region: 2027-2032
  5. 5.3 Global Cefdinir Capsules Revenue by Region: 2021-2032
  6. 5.3.1 Global Cefdinir Capsules Revenue by Region: 2021-2026
  7. 5.3.2 Global Cefdinir Capsules Revenue by Region: 2027-2032
  8. 5.4 North America Cefdinir Capsules Market Facts & Figures by Country
  9. 5.4.1 North America Cefdinir Capsules Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Cefdinir Capsules Sales by Country (2021-2032)
  11. 5.4.3 North America Cefdinir Capsules Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Cefdinir Capsules Market Facts & Figures by Country
  16. 5.5.1 Europe Cefdinir Capsules Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Cefdinir Capsules Sales by Country (2021-2032)
  18. 5.5.3 Europe Cefdinir Capsules Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Cefdinir Capsules Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Cefdinir Capsules Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Cefdinir Capsules Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Cefdinir Capsules Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Cefdinir Capsules Market Facts & Figures by Country
  41. 5.7.1 South America Cefdinir Capsules Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Cefdinir Capsules Sales by Country (2021-2032)
  43. 5.7.3 South America Cefdinir Capsules Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Cefdinir Capsules Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Cefdinir Capsules Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Cefdinir Capsules Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Cefdinir Capsules Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Cefdinir Capsules Sales by Type (2021-2032)
  2. 6.1.1 Global Cefdinir Capsules Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Cefdinir Capsules Sales Market Share by Type (2021-2032)
  4. 6.2 Global Cefdinir Capsules Revenue by Type (2021-2032)
  5. 6.2.1 Global Cefdinir Capsules Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Cefdinir Capsules Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Cefdinir Capsules Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Cefdinir Capsules Sales by Application (2021-2032)
  2. 7.1.1 Global Cefdinir Capsules Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Cefdinir Capsules Sales Market Share by Application (2021-2032)
  4. 7.2 Global Cefdinir Capsules Revenue by Application (2021-2032)
  5. 7.2.1 Global Cefdinir Capsules Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cefdinir Capsules Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Cefdinir Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Cefdinir Capsules Value Chain Analysis
  2. 8.1.1 Cefdinir Capsules Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Cefdinir Capsules Production Mode & Process
  5. 8.2 Cefdinir Capsules Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Cefdinir Capsules Distributors
  8. 8.2.3 Cefdinir Capsules Customers
9 Global Cefdinir Capsules Analyzing Market Dynamics
  1. 9.1 Cefdinir Capsules Industry Trends
  2. 9.2 Cefdinir Capsules Industry Drivers
  3. 9.3 Cefdinir Capsules Industry Opportunities and Challenges
  4. 9.4 Cefdinir Capsules Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst